
Sign up to save your podcasts
Or


[Running time: 13 minutes]
The 2008 and 2012 recommendations from the USPSTF regarding PSA-based prostate screening have been accompanied by drops in both the screening and detection rates of prostate cancer, two studies in JAMA find.
Our guest, Dr. David Penson, wrote an editorial accompanying those studies. It attempts to put these new findings into perspective and to help the patients and physicians caught in the middle of a continuing debate on the wisdom of screening.
Physician’s First Watch coverage of the JAMA studies and editorial (free)
By NEJM Group4.5
5656 ratings
[Running time: 13 minutes]
The 2008 and 2012 recommendations from the USPSTF regarding PSA-based prostate screening have been accompanied by drops in both the screening and detection rates of prostate cancer, two studies in JAMA find.
Our guest, Dr. David Penson, wrote an editorial accompanying those studies. It attempts to put these new findings into perspective and to help the patients and physicians caught in the middle of a continuing debate on the wisdom of screening.
Physician’s First Watch coverage of the JAMA studies and editorial (free)

7,712 Listeners

319 Listeners

2,056 Listeners

125 Listeners

505 Listeners

303 Listeners

896 Listeners

269 Listeners

3,371 Listeners

112,284 Listeners

90 Listeners

5 Listeners

90 Listeners

517 Listeners

2,551 Listeners

376 Listeners

16,236 Listeners

58 Listeners

38 Listeners

61 Listeners